STOCK GRAM

Sensex Today | Stock Market LIVE Updates: Nifty 50 trades below 24,700; Yes Bank shares up 5%

Published on: June 2, 2025, 12:11 pm

Source: CNBCTV18

The shares of Apollo Hospitals hit and therefore regained the ₹7,000 mark. The company shares surged by over 1.7%. This came to pass after the company announced its Q4 results.

Net profit came in 19% higher than estimates, supported by stronger-than-expected other income and a lower tax rate.

Read More

As the market lies low in red, the Nifty Realty index is on the rise. The index soared by over 1.1% on Monday.

Some of the major contributors to the surge include the likes of

Brigade Enterprises surged by over 4.5%

The shares of Prestige Estates increased in value by over 3.8%

Anantraj shares increased by over 4%

Ankur Gupta, MD Brookfield, Schloss (The Leela) On CNBC-TV18

It’s A Momentous Day For Hospitality Industry In India

Advanced Prog To Create Leela Palace In Mumbai, Added A New Property In Powai

Have Stated Our Objective To Take The Brand Global

We Are Long Term Investors

With Proliferation Of GCCs, There Is A Need For High Quality Accommodation

Brookfield Has Experience In Rental Service Apartments

See Opportunity With Leela Residency Opening In Mumbai Early Next Year

Tripled The Biz In Last 5 Years; Co Has Defined Biz Plan & A Healthy Balance Sheet

The shares of Maruti Suzuki are under pressure. The shares of the automaker dipped by over 1% after the company reported its auto sales numbers for May.

In the exchange filing published on Monday, June 2, the company reported a total sales number of 1,80,077 units. Sales within the Passenger Vehicle segments dropped to 1,35,962 units compared to 1,44,002 units it sold in May 2024.

Read More

The shares of technology solutions provider Mphasis Ltd. fell as much as 5% on Monday, June 2, after Mint reported that it had lost one of its oldest clients, FedEx.

According to the report, FedEx accounted for 8% of Mphasis’s overall revenue.

Read More

Luxury hospitality chain Schloss Bangalore, which owns and operates hotels under the iconic “The Leela” brand listed on the bourses on Monday, June 2. The stock made a weak debut after listing at nearly a 7% discount on the exchanges. The stock listed at ₹406 on NSE, meanwhile, it was priced at ₹406.50 on BSE.

Market Watch: Prakash Diwan, Market Expert (fundamental)

On Nykaa

I think that there’s this very clear turnaround in terms of path to profitability, and the approach to the business itself. But most of these companies having done enough mistakes vis-a-vis what the Street expectation is, but is Nykaa part of that list in terms of turning around? I think it still needs more time. If you see what any of these New Age companies where opportunity exists from a defined trajectory on those turnaround, why not a Zomato? Why not a Paytm? These are companies which very clearly have demonstrated that the change is irreversible. Nykaa still needs to kind of the same thing happened with Mamaearth the day you had good numbers, but it couldn’t sustain. So that’s the whole challenge. They’ll have to establish the trajectory unequivocally, and then probably the market will start wanting to kind of put something – things have improved, margins have improved, but then they still need to relook at the business model. Why carry the burden of fashion when it’s not doing well for so many quarters? So there’s lots of questions that they will probably have answers to, but we’ll get to see that on the ground, and then then look at it, but not too excited to buy into it at this point in time.

On Onesource

Onesource has been a developing story, if I may use one of your terms, in that sense that it always held a lot of promise, given how it started off and branched off and on the market as well, the way it’s been creating its trailblazing kind of moves. This verdict establishes a lot of things, keeps all the doubts away. And Semaglutide as an opportunity is something which, whichever way companies participate, is going to be promising enough. So I don’t think these restrictions will not allow them to export. And there’s a massive market overseas, which they still have accessible. So I am quite positive on that. Onesource Speciality also has other things than this that are very positive. So take a look at it from a constructive perspective. It could definitely surprise the market.